A study came out last week that should have caused great alarm. For 13 years, researchers at the University of Copenhagen studied more than a million women between the ages of 15 and 34 who were taking a type of drug — one that is popular in all developed countries. Taking this drug, the researchers found, correlated with an increase in the risk of depression. The correlation was particularly strong in adolescent girls, who showed an 80 per cent higher chance of being diagnosed with depression.
Usually when a story about women’s health and depression breaks, a phalanx of activists and campaigners pop up all over the media to ‘raise awareness’ of the issue. Last week, however, barely a peep — the papers carried the story and a few online sites ran delicately objective surveys of women on the pill, but there were few howls of outrage.
Why the muted response? The answer is that the type of drug in question was hormonal contraception, and it is today a sin just to suggest that it may not be the greatest gift ever given to womankind.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in